These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33578538)

  • 1. A double mutation of BRAF L597Q and V600E in situ and solitary brain metastasis of occult papillary thyroid carcinoma: A case report.
    Chen L; Wu Y; Bai H; Liu H; Li X
    Medicine (Baltimore); 2021 Feb; 100(6):e24458. PubMed ID: 33578538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
    Huang M; Yan C; Xiao J; Wang T; Ling R
    Diagn Pathol; 2019 Jul; 14(1):74. PubMed ID: 31300059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between BRAF
    Shangguan R; Hu YP; Huang J; Yang SJ; Ye L; Lin RX; Zhu J; Zhang TL; Ying L; Li P
    Acad Radiol; 2019 Feb; 26(2):154-160. PubMed ID: 29941398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.
    Al-Salam S; Sharma C; Afandi B; Al Dahmani K; Al-Zahrani AS; Al Shamsi A; Al Kaabi J
    PLoS One; 2020; 15(4):e0231341. PubMed ID: 32315324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninferior response in BRAF(V600E) mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy.
    Li J; Liang J; Zhao T; Lin Y
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1034-9. PubMed ID: 26780618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF(V600E) mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma.
    Jing FJ; Liang J; Liang ZY; Meng C; Long W; Li XY; Lin YS
    Chin Med J (Engl); 2013 Aug; 126(16):3013-8. PubMed ID: 23981603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF
    Shi C; Cao J; Shi T; Liang M; Ding C; Lv Y; Zhang W; Li C; Gao W; Wu G; Man J
    World J Surg Oncol; 2020 Jun; 18(1):145. PubMed ID: 32593310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    He H; Li W; Yan P; Bundschuh R; Killian JA; Labanowska J; Brock P; Shen R; Heerema NA; de la Chapelle A
    Thyroid; 2018 Jun; 28(6):748-754. PubMed ID: 29768105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of the BRAF V600E Mutation and PAQR3 Protein Expression with Papillary Thyroid Carcinoma Clinicopathological Features.
    Gao J; Ma XP; Deng FS; Jiang L; Jia WD; Li M
    Pathol Oncol Res; 2020 Jul; 26(3):1833-1841. PubMed ID: 31758408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
    Daliri M; Abbaszadegan MR; Bahar MM; Arabi A; Yadollahi M; Ghafari A; Taghehchian N; Zakavi SR
    Endocr Res; 2014; 39(4):189-93. PubMed ID: 24679337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The co-relation of BRAF V600E mutation and factors affecting occurrence and prognosis of papillary thyroid carcinoma].
    Wang J; Liu LT; Cui D; He L; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):288-292. PubMed ID: 30955264
    [No Abstract]   [Full Text] [Related]  

  • 12. Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K.
    Han F; Zhang L; Zhang S; Zhou H; Yi X
    Int J Clin Exp Pathol; 2015; 8(5):5896-901. PubMed ID: 26191315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between BRAF
    Zhou B; Hei H; Li YQ; Zhang DY; Wang DQ; Qin JW
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(14):1060-1063. PubMed ID: 37032157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
    Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
    Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation of sodium iodide symporter and BRAF(V600E) mutation in classical variant papillary thyroid carcinoma.
    Yazgan A; Yıldırım N; Gözalan A; Gümüştaş S; Kılıçarslan A; Balci S; Aydın C; Ersoy R; Cakir B; Güler G
    Ann Diagn Pathol; 2016 Jun; 22():58-62. PubMed ID: 27180062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Tumor DNA Harboring the
    Sato A; Tanabe M; Tsuboi Y; Niwa T; Shinozaki-Ushiku A; Seto Y; Murakami Y
    Thyroid; 2021 Dec; 31(12):1822-1828. PubMed ID: 34541884
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is rare, benign lesion using modified stringent diagnostic criteria: Reclassification and outcome study.
    Cubero Rego D; Lee H; Boguniewicz A; Jennings TA
    Ann Diagn Pathol; 2020 Feb; 44():151439. PubMed ID: 31865250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Analysis of BRAF
    Dong SY; Chen J; Xia EJ; Lin RX; Du HY; Wang OC; Zhang XH; Hao RT
    Am Surg; 2020 May; 86(5):450-457. PubMed ID: 32684022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel genomic variance of BRAF1 in papillary thyroid carcinoma: A case report.
    Wang Y; Zhao J; Tan Z; Du J; Zhang L; Xu Y; Li X; Cai Y; Wang H; Jiang J
    Medicine (Baltimore); 2024 Jan; 103(3):e36978. PubMed ID: 38241570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma.
    Lu J; Gao J; Zhang J; Sun J; Wu H; Shi X; Teng L; Liang Z
    Int J Clin Exp Pathol; 2015; 8(1):793-9. PubMed ID: 25755776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.